Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes.

Authors

Christine N. DuncanFollow
Navneet S. Majhail
Ruta Brazauskas
Zhiwei Wang
Jean-Yves Cahn
David A. Jacobsohn, George Washington UniversityFollow
et al.

Document Type

Journal Article

Publication Date

1-1-2015

Journal

Biology of Blood and Marrow Transplantation

Volume

21

Issue

1

Inclusive Pages

151-158

DOI

10.1016/j.bbmt.2014.10.006

Keywords

Hematopoietic Stem Cell Transplantation--methods; Leukemia, Myeloid, Acute--therapy; Myeloablative Agonists--therapeutic use; Myelodysplastic Syndromes--therapy; Transplantation Conditioning

Comments

PMCID: PMC4272862 [Available on 2016-01-01]

APA Citation

Duncan, C. N., Majhail, N. S., Brazauskas, R., Wang, Z., Cahn, J. -., Frangoul, H. A., . . . Sorror, M. L. (2015). Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes. Biology of Blood and Marrow Transplantation, 21(1), 151-158.

Peer Reviewed

1